Search results for "type 2"

showing 10 items of 1034 documents

Phosphomannosyl receptors of lysosomal enzymes of skeletal muscle in neuromuscular diseases.

1988

The phosphomannosyl receptor system is responsible for both the receptor-mediated endocytosis and the intracellular transport of lysosomal enzymes. In the present study this receptor system was examined in affected muscles of patients with various neuromuscular diseases. The total activity of beta-N-acetyl-glucosaminidase, a marker enzyme of lysosomal hydrolases, was significantly elevated in the patients with myopathies (polymyositis and muscular dystrophies) but only slightly increased in those with neurogenic muscle atrophies (amyotrophic lateral sclerosis, polyneuropathy or other neurogenic muscle disease). The increase was most prominent in the group of polymyositis. The content of pho…

AdultMalemedicine.medical_specialtyNeuromuscular diseaseAdolescentReceptors Cytoplasmic and NuclearReceptors Cell SurfaceBiologyPolymyositisReceptor IGF Type 2Internal medicineLysosomemedicineHumansAmyotrophic lateral sclerosisMuscular dystrophyReceptorAgedMusclesSkeletal muscleGeneral MedicineNeuromuscular DiseasesMiddle Agedmedicine.diseaseMuscle atrophymedicine.anatomical_structureEndocrinologyNeurologyFemaleNeurology (clinical)medicine.symptomLysosomesActa neurologica Scandinavica
researchProduct

Assessment of induced corneal hypoxia in diabetic patients

2002

Comparative Study Address correspondence and reprint requests to Dr. C. Creuzot-Garcher, Service d'Ophtalmologie, CHU, Hopital Général, 3 Rue du Faubourg Raines, BP 1519, 21033 Dijon, France. E-mail: Catherine.creuzot-garcher@chu-dijon.fr; To assess the control of corneal hydration in patients with diabetes during a contact lens-induced hypoxia. Corneal stress was induced in 15 patients with diabetes and 23 healthy patients by having them wear contact lenses for 2 hours. Pachymetries were measured and corneal parameters (percentage recovery per hour [PRPH], time for deswelling [T99%] and induced swelling [IS]) were calculated. In the mean time, tears were collected to assess the activity of…

AdultMalemedicine.medical_specialtyPathologyCell CountCorneachemistry.chemical_compoundStress PhysiologicalOphthalmologyLactate dehydrogenaseDiabetes mellitusHumansMedicineIn patient[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansHypoxiaAged[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyL-Lactate Dehydrogenasebusiness.industryCorneal EdemaEndothelium CornealMiddle AgedHypoxia (medical)Contact Lenses Hydrophilicmedicine.diseaseeye diseasesOphthalmologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2chemistry[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansTearsTearsFemaleCorneal hypoxiasense organsmedicine.symptomSwellingbusinessAnaerobic exercise[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Reduction of HbA1c levels following nonsurgical treatment of periodontal disease in type 2 diabetics

2009

Objectives: A study was made of the effect of nonsurgical periodontal treatment upon blood glucose control in type 2 diabetics with periodontal disease. Study design: A pre-post repeated measures analytical design was used, with a PubMed search of the related articles published up until December 2008. Results: The improvement in glycosylated hemoglobin (HbA1c) after nonsurgical periodontal treatment on comparing the baseline (8.0290±1.5539) and final values (7.7806±1.5636) was 0.2483±0.1171, and proved statistically significant (p=0.042). Conclusions: A decrease in HbA1c was observed after treatment, thus indicating improved blood glucose control in type 2 diabetics with periodontal disease.

AdultMalemedicine.medical_specialtyPeriodontal treatmentGlucose controlDentistryHba1c levelPeriodontal diseaseInternal medicinemedicineHumansGeneral DentistryPeriodontal DiseasesAgedAged 80 and overGlycated Hemoglobinbusiness.industryRepeated measures designMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Nonsurgical treatmentDiabetes Mellitus Type 2OtorhinolaryngologyUNESCO::CIENCIAS MÉDICASFemaleSurgeryHemoglobinbusinessAfter treatment
researchProduct

Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the…

2004

Aims Patients with diabetes are at excessive risk of mortality and cardiovascular morbidity. Previous studies suggest that aspirin may be less effective in diabetic patients. In this multi-centre, randomized, double blind trial picotamide, a dual inhibitor of thromboxane A2 synthase and receptor, was compared with aspirin for the prevention of mortality and major cardiovascular events in diabetics with peripheral arterial disease (PAD). Methods and results A total of 1209 adults aged 40–75 years with type 2 diabetes and PAD were randomized to receive picotamide (600 mg bid) or aspirin (320 mg od) for 24 months. The cumulative incidence of the 2 years overall mortality was significantly lowe…

AdultMalemedicine.medical_specialtyPhthalic AcidsType 2 diabetesDiabeteGastroenterologyThromboxane A2Double-Blind MethodRisk FactorsInternal medicineDiabetes mellitusPeripheral arterial diseasemedicineRisk of mortalityHumansPicotamideCumulative incidenceGeneral NursingAgedPeripheral Vascular DiseasesAspirinAspirinbiologybusiness.industryAntiplatelet therapyantiplatelet therapy; aspirin; diabetes; peripheral arterial disease; picotamide; thromboxane synthase inhibitorsMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryThromboxane synthase inhibitors Indexed keywordsRelative riskbiology.proteinFemaleThromboxane-A synthasePicotamideCardiology and Cardiovascular MedicinebusinessDiabetic AngiopathiesPlatelet Aggregation InhibitorsFollow-Up Studiesmedicine.drugEuropean Heart Journal
researchProduct

Effects of a home-based rehabilitation program in obese type 2 diabetics.

2012

International audience; OBJECTIVE: To assess, in obese type 2 diabetics (T2D), the impact of a home-based effort training program and the barriers to physical activity (PA) practice. METHOD: Twenty-three obese T2D patients (52.7 ± 8.2 years, BMI = 38.5 ± 7.6 kg/m(2)) were randomized to either a control group (CG), or an intervention group (IG) performing home-based cyclergometer training during 3 months, 30 min/day, with a monthly-supervised session. The initial and final measurements included: maximal graded effort test on cyclergometer, 6-minute walk test (6MWT) and 200-meter fast walk test (200mFWT), quadriceps maximal isometric strength, blood tests and quality of life assessment (SF- 3…

AdultMalemedicine.medical_specialtyQuadriceps strength030209 endocrinology & metabolismIsometric exerciseType 2 diabetes03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationQuality of lifeHumansMedicineOrthopedics and Sports MedicineMuscle StrengthObesityProspective Studies030212 general & internal medicineProspective cohort studyExerciseAgedbusiness.industry[SCCO.NEUR]Cognitive science/NeuroscienceRehabilitationMiddle Agedmedicine.disease3. Good healthTest (assessment)Diabetes Mellitus Type 2Home based rehabilitation[ SCCO.NEUR ] Cognitive science/NeuroscienceExercise TestPhysical therapyFemaleTraining programbusiness
researchProduct

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

2020

Digital

AdultMalemedicine.medical_specialtyRecombinant Fusion ProteinsGlucagon-Like Peptides030209 endocrinology & metabolismType 2 diabetesPlacebolaw.invention03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicinemedicineHumansHypoglycemic AgentsCognitive DysfunctionRisk factorAgedbusiness.industryHazard ratioMontreal Cognitive AssessmentMiddle Agedmedicine.diseaseImmunoglobulin Fc FragmentsTreatment OutcomeDiabetes Mellitus Type 2Digit symbol substitution testFemaleDulaglutideNeurology (clinical)business030217 neurology & neurosurgerymedicine.drug
researchProduct

Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients

2015

Diabetic foot ulcerations have been extensively reported as vascular complications of diabetes mellitus associated with a high degree of morbidity and mortality; in fact, some authors showed a higher prevalence of major, previous and new-onset, cardiovascular, and cerebrovascular events in diabetic patients with foot ulcers than in those without these complications. This is consistent with the fact that in diabetes there is a complex interplay of several variables with inflammatory metabolic disorders and their effect on the cardiovascular system that could explain previous reports of high morbidity and mortality rates in diabetic patients with amputations. Involvement of inflammatory marke…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismInflammationType 2 diabetesReview ArticleCardiovascular Systemlcsh:Diseases of the endocrine glands. Clinical endocrinologyEndocrinologyRisk FactorsDiabetes mellitusInternal medicinemedicineAlbuminuriaAnimalsHumansAgedDyslipidemiasInflammationlcsh:RC648-665Adiponectinbusiness.industryInterleukin-6Mortality rateMiddle Agedmedicine.diseaseDiabetic footDiabetic FootEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesImmune SystemHypertensionAlbuminuriaResistinFemalemedicine.symptombusinessdiabetic foot inflammation marker
researchProduct

Thrombin-antithrombin III complexes in type II diabetes mellitus.

1992

Several studies suggest that diabetes is associated with a hypercoagulable state. Therefore determination of thrombin-antithrombin complex (TAT) could represent a sensitive parameter for specific detection of a latent activation of the clotting system. The present study documents increased plasma TAT in a heterogeneous group of non-insulin-dependent diabetic patients. The finding of increased TAT levels both in diabetic patients with vascular complications and in vascular disease patients without diabetes suggests a relationship between existing vascular disease and the hemostatic mechanism that produces augmented thrombin activity. In acute vascular occlusions the presence of diabetes seem…

AdultMalemedicine.medical_specialtySpecific detectionEndocrinology Diabetes and MetabolismAntithrombin IIIType ii diabetesEndocrinologyReference ValuesDiabetes mellitusInternal medicineInternal MedicinemedicineHumansAgedAged 80 and overHeterogeneous groupVascular diseasebusiness.industryThrombin/Antithrombin IIIAge FactorsThrombinMiddle Agedmedicine.diseaseCerebrovascular DisordersCoagulative necrosisEndocrinologyDiabetes Mellitus Type 2Thrombin activityRegression AnalysisFemalebusinessDiabetic AngiopathiesJournal of diabetes and its complications
researchProduct

Ultrasonic evaluation with second harmonic imaging and SonoVue in the assessment of cerebral perfusion in diabetic patients: a case-control study

2004

The purpose was to compare human brain tissue perfusion in diabetic patients and healthy subjects with second harmonic imaging ultrasound and SonoVue to test the hypothesis that brain tissue perfusion differences are present in these two groups of patients. In a prospective case-control study, second harmonic examinations performed in 20 patients with type II diabetes mellitus and in 20 matched control patients were compared. After administration of 2.5 ml of SonoVue, 60 time-triggered images were recorded. Time-intensity curves, including peak intensity and positive gradient normalized to the middle cerebral artery, were calculated to quantify ultrasound intensity in a region of interest. …

AdultMalemedicine.medical_specialtySulfur Hexafluoridemedicine.arteryInternal medicineUltrasoundHumansMedicineRadiology Nuclear Medicine and imagingProspective StudiesCerebral perfusion pressurePhospholipidsAgedUltrasonographyNeuroradiologyHarmonic studybusiness.industryContrast mediaUltrasoundCase-control studyBrainGeneral MedicineBlood flowBlood flowMiddle AgedSurgeryIntensity (physics)PerfusionDiabetes Mellitus Type 2Case-Control StudiesCerebrovascular CirculationMiddle cerebral arteryCardiologyFemaleRadiologybusinessPerfusion
researchProduct

Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus.

2004

Abstract Triflusal is an antiplatelet drug related to aspirin, with different pharmacological properties and a lower haemorrhagic risk. We aimed at comparing their effects on platelet and endothelial activation in type 2 diabetes mellitus (T2DM). In a randomized, double-blind, parallel group study, we compared the effects of three daily regimens (300, 600, and 900mg) of triflusal, and aspirin (100mg/day) on urinary 11-dehydro-thromboxane (TX)B 2 , index of in vivo platelet activation, ex vivo platelet function using the analyzer PFA-100, plasma von Willebrand factor (vWF), P-selectin, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and serum nitrite a…

AdultMalemedicine.medical_specialtyThromboxaneaspirinRadioimmunoassaychemistry.chemical_compoundThromboxane A2Von Willebrand factorDouble-Blind MethodInternal medicinetype 2 diabetes triellitusvon Willebrand Factormedicineplatelet activationHumansPlateletPlatelet activationAgedRetrospective StudiesAspirinbiologyDose-Response Relationship DrugMiddle AgedSalicylatesThromboxane B2Thromboxane B2triflusalP-SelectinEndocrinologychemistryDiabetes Mellitus Type 2biology.proteinTriflusalFemaleCardiology and Cardiovascular MedicineBiomarkersPlatelet Aggregation Inhibitorsmedicine.drugFollow-Up Studies
researchProduct